Novavax's market cap is currently $1.32B. The company's EPS TTM is $-2.26; its P/E ratio is ―; Novavax is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 556.38M	$ 1.60B	$ 1.15B	$ 475.60M	$ 18.66M
Gross Profit	$ 212.61M	$ 696.31M	$ 1.13B	$ -271.43M	$ -95.18M
Operating Income	$ -566.51M	$ -644.74M	$ -1.69B	$ -416.72M	$ -120.58M
EBITDA	$ -487.39M	$ -604.71M	$ -1.68B	$ -398.23M	$ -114.83M
Net Income	$ -545.06M	$ -657.94M	$ -1.74B	$ -427.50M	$ -130.10M
Balance Sheet
Cash & Short-Term Investments	$ 568.50M	$ 1.34B	$ 1.52B	$ 711.05M	$ 78.82M
Total Assets	$ 1.80B	$ 2.26B	$ 2.58B	$ 1.58B	$ 172.96M
Total Debt	$ 229.08M	$ 549.78M	$ 453.99M	$ 322.04M	$ 321.87M
Net Debt	$ -339.42M	$ -787.10M	$ -1.06B	$ -231.36M	$ 243.05M
Total Liabilities	$ 2.51B	$ 2.89B	$ 2.93B	$ 955.27M	$ 358.97M
Stockholders' Equity	$ -716.93M	$ -634.08M	$ -351.67M	$ 627.21M	$ -186.02M
Cash Flow
Free Cash Flow	$ -772.77M	$ -508.92M	$ 265.46M	$ -97.16M	$ -138.48M
Operating Cash Flow	$ -713.97M	$ -415.94M	$ 322.95M	$ -42.54M	$ -136.62M
Investing Cash Flow	$ -58.81M	$ -92.98M	$ 100.15M	$ -377.78M	$ 38.49M
Financing Cash Flow	$ 4.47M	$ 324.99M	$ 461.71M	$ 984.76M	$ 98.38M

Currency in USD

Novavax Earnings and Revenue History

Income Statement >

Novavax Debt to Assets

Balance Sheet >

Novavax Cash Flow

Cash Flow >

Novavax Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing